Among young oncologists, women encounter more difficulties than men in attending conferences and this may affect their professional satisfaction. This is the key message of a survey conducted by a group of researchers of the [more]
Labels containing warnings on the health risks associated with alcohol consumption are usually not noticed and remembered by teenagers, who should be in principle among the main targets. According to a study published in the Jou [more]
Despite the prominent global debate on the ethics of technology and the increasing need for technology assessment before approval, anticipatory approaches, especially in oncology, are still in their infancy In the age of artificial intelligence [more]
Launched in late June this year, the 2019 WHO Report “Offer help to quit tobacco use” claims that 5 billion people (65% of the world’s population) are exposed to at least one measure to control the [more]
A new study on the allocation of research funding in the United States concluded that highly deadly cancer types are under-supported. This may be at least partially due to the impact of emotional choices on [more]
The potential for combining radiotherapy with immunotherapy is enormous, yet experts say that radio-immunotherapy still has a long way to go before entering into routine clinical practice One of the hot topics discussed at ESTRO38, [more]
No longer children and not yet adults, adolescents and young adults with cancer represent a specific patient population posing outstanding challenges to oncologists all over the world. Challenging but rewarding. This is how physicians described [more]
Almost half (47%) of patients with cancer do not think that they have been sufficiently involved in the treatment decision process. This is what the international All.Can cancer initiative reveals in its report Patient insights [more]
Almost 95 billion dollars of lost earnings. That’s the estimated price USA paid in 2015 for cancer-related deaths in people aged 16 to 84 years, according to a paper recently published in JAMA Oncology by [more]
With the advent of Open Access – a new publishing model that asks researchers to pay to make their research publicly accessible – unscrupulous predators were granted easy access to a house full of naïve and ingenuous scientists and doctors, and today thrive at their expense, and at the expense of science, including cancer research. [more]
Cancer patient advocates from 26 European countries, active across a wide spectrum of cancer types, spent four days last week at the first training course to be developed and run by advocates themselves.The intensive training ‘Academy’ was organised by WECAN [more]
Seminal data from decades ago already demonstrated a marked underrepresentation of older patients in clinical trials: now an analysis of more than 300 randomised clinical trials (RCTs) shows not only that the disparity persists but the gap between trial and population median ages is widening. [more]
What’s the real story? This month Cancer World launches its latest Journalism Award, and it’s more important than it’s ever been. A year ago, the overall winner of the last award explained why it meant so much to her.
“I am glad that the voices of the poorest Indian cancer patients are heard across the world and I hope there is an improvement in their access to treatment,” said Swagata [more]